1. Introduction to the Project

1.1 Introduction to technical achievements

The project focuses on the research and development of surgical navigation systems. The Image Guided System (IGS) is a visual image-guided surgical technology developed based on medical image data such as MRI and CT, using computers and image processing. It belongs to medical devices with the high technical content. Real-time tracking of patient lesion tissue can be achieved through 3D digitization, thereby assisting doctors or robots in completing surgical tasks more quickly, accurately, and safely.

1.2 Technical analysis and advantages

1.2.1 Core technical analysis

Jilin Site’an Digital Medical Technology Co., Ltd. is committed to the research and development, production of digital medical products. The independently developed “endoscopic IGS” product has mastered core technologies such as real-time navigation modeling algorithms and is at the leading level in China.

1.2.2 Technological innovation and advantages

The product technology of this project is excellent and has formed a technical barrier in China, breaking the gap in the biopharmaceutical and medical device industry in Jilin Province; in addition, the product design conforms to the operating habits of domestic doctors, with obvious localization advantages, and the product has independent intellectual property rights, which gives it a cost advantage compared to other production enterprises.

1.3 Main products and applications of technical achievements

The main product of the project is the endoscopic IGS, which can be applied to multiple departments such as urology, gynecology, cardiothoracic surgery, and general surgery, providing more minimally invasive solutions for cross-departmental and multi-indication treatment.

1.4 Technical achievement commercialization and market promotion

1.4.1 Stage of technological achievements

At present, the technical achievements of this project are in the small trial stage.

1.4.2 Technical achievement marketing promotion plan

The promotion plan for the technical achievements of the project mainly includes the following aspects:

(1) Fully utilize the national endoscope sales network system in Tonglu County, Hangzhou City for sales;

(2) Utilize the market channel system of Daan Gene to establish sales channels with medical device enterprises and 2A or above hospitals;

(3) Collaborate with endoscope manufacturing enterprises to produce medical endoscope systems with navigation functions;

(4) Targeted deployment of IGS in surgical operating rooms to profit from surgical service fees;

(5) Implant the IGS into the entire operating room solution;

(6) Establish a cooperative distribution model with sales agents through the Medical Expo;

(7) Obtain the market demand and promote the products through professional medical device B2B platforms.

1.5 Technical team

Jilin Site’an Digital Medical Technology Co., Ltd. (under registration) is an innovative enterprise with a university gene that integrates production and research; the R&D team of Site’an comes from the Jilin Medical Imaging Computing Engineering Laboratory of Changchun University of Science and Technology (hereinafter referred to as the laboratory), which is a provincial-level key laboratory recognized by Jilin Provincial Development and Reform Commission. The laboratory is committed to tackling industry bottlenecks and conducting forward-looking technological research in the field of computer-aided diagnosis and treatment. The achievements developed by the technical team have won first and third prizes in provincial-level scientific and technological progress, as well as first prizes in municipal level scientific and technological progress. They have been clinically practiced in multiple3A hospitals, including the General Hospital of the People’s Liberation Army, Nanfang Hospital, the First Hospital of Jilin University, the Second Hospital of Jilin University, and China-Japan Union Hospital of Jilin University.

Among them, the laparoscopic IGS workstation completed the first clinical trial of computer-assisted IGS for total gastrectomy via abdominal cavity in China at Nangfang Hospital; it has conducted live surgical navigation demonstrations multiple times at the International Symposium on Laparoscopic Gastrointestinal Surgery of the Chinese Medical Association.

2. Market Potential Analysis

The IGS technology was first developed in the North American and European markets. In this region, some companies represented by Medtronic, Brainlab, GE, Stryker, and others have the high brand awareness and market share in the global IGS market.

In 1997, the Neurosurgery Department of Huashan Hospital affiliated with Fudan University introduced the first Medtronic StealthStation neuronavigation system, which showed many enterprises its commercial potential. Two years later, Shenzhen Anke Co., Ltd. developed the first domestically produced surgical navigation system. The Excelim-04 neurosurgical navigation system developed by Shanghai Fudan Digital Medical Technology Co., Ltd. was awarded a Class III medical device certificate by the National Medical Products Administration in November, 2006. On September 15, 2006, the former Ministry of Health of the People’s Republic of China announced in its project application that the “research on image guided system” was prominently included. In 2014, 2016, and 2018, the government issued multiple policies to provide a green light for the approval of innovative medical devices, including surgical navigation. On May 21, 2020, the National Health Commission issued a document encouraging hospitals at or above the second level to promote the development and application of intelligent medical equipment such as surgical robots and surgical navigation positioning, promote the application of intelligent auxiliary systems for disease diagnosis, treatment, rehabilitation, and care, and improve the efficiency of medical services. A group of leading enterprises in the field of IGS are constantly emerging in China, including Sino Precision, Ariemedi, EDDA, B Remebot, Dcarer, Ailifeng and other companies competing on the same stage. In recent years, with the gradual deepening of research on IGS by relevant universities, research institutes, and enterprises in China, the technology of the domestic IGS industry has made significant progress. On the one hand, domestic neurosurgical IGS have reached the international advanced level. On the other hand, through continuous technological research and innovation, China has successfully expanded the application fields of domestic IGS and developed a navigation device that can be used for the adult lung and abdominal solid organ puncture surgery.

From the perspective of the market prospects of IGS, thanks to the advancement of technologies such as artificial intelligence, medical imaging, spatial positioning, and virtual reality, as well as the promotion of precision medicine, the “Healthy China 2030” policy, and the development of minimally invasive and non-invasive treatment surgery industries, the development prospects of China’s IGS industry are continuously improving. In the future, with the continuous increase in domestic surgical demand, the market size of China’s IGS industry is expected to further expand.

The IGS can make surgeries faster, more accurate, and safer, meeting the current and future surgical treatment needs. It is widely used in various fields such as neurosurgery, orthopedics, spine, otolaryngology, plastic surgery, and prostate surgery. In recent years, attracted by the promising market prospects, the number of participants in the IGS industry has increased, and the market competition pattern has also undergone certain changes. However, existing enterprises and potential entrants in the IGS industry still need to increase technological innovation to improve their competitiveness and make the IGS more reliable, stable, flexible, and safe.

The main product of this project is the endoscopic IGS, which has the excellent technology and is widely used in multiple departments such as urology, gynecology, cardiothoracic surgery, and general surgery. It breaks the gap in the biopharmaceutical and medical device industry in Jilin Province and has the development potential.

3. Financing Needs and Stage Goals

The IGS technology achievement commercialization project is planned to raise 2 million yuan, which will be invested in product development and promotion. The phased goals are as follows:

(1) It is expected to complete product finalization before June 30, 2024;

(2) It is expected to complete product registration inspection before December 31, 2024.

Utilize about three years of time to deeply cultivate the domestic market, increase product market share, enhance brand awareness, and strive to become a well-known listed enterprise in the field of IGS in China in five years; strengthen the deepening cooperation with well-known experts in the international field, always maintain the progressiveness technology, expand the international market and influence, and strive to become the international leading enterprise in the field of precision medicine.

4. Analysis of Technical Achievements and Benefits

4.1 Economic benefits

The market value of the technical achievements of the project is 15 million yuan.

4.2 Social benefits

After the registration and inspection of the “endoscopic IGS” independently developed by the project with the IGS as the core, it can fill the gap in the biopharmaceutical and medical device industry in Jilin Province, and promote the high-quality development of the medical and health industry in Jilin Province.

5. Contact Method

Contact person: Song Xiaolong

Tel: 13756302255